共 195 条
[1]
Khojasteh A(2013)Healing of extraction sockets and augmented alveolar defects following 1-year treatment with bisphosphonate J Craniofac Surg 24 e68-e73
[2]
Behnia H(2016)Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw Dental Hypotheses 7 56-1045
[3]
Morad G(2008)Bisphosphonates: mechanism of action and role in clinical practice Mayo Clin Proc 83 1032-1956
[4]
Dashti SG(2014)American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update J Oral Maxillofac Surg 72 1938-130
[5]
Dehghan MM(2009)American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update Aust Endod J 35 119-1024
[6]
Shahab S(2007)Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis J Natl Cancer Inst 99 1016-5362
[7]
Abbas FM(2009)Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw J Clin Oncol 27 5356-1491
[8]
Nazeman P(2007)Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 1479-423
[9]
Rad MR(2007)Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 415-609
[10]
Khojasteh A(2009)Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies Gynecol Oncol 112 605-462